Skip to main content

. 1989 Sep 2;299(6699):604–605. doi: 10.1136/bmj.299.6699.604

Changes in glucose tolerance and development of gall stones during high dose treatment with octreotide for acromegaly.

J A McKnight ¹, D R McCance ¹, J G Crothers ¹, A B Atkinson ¹

PMCID: PMC1837463 PMID: 2508821

604

Images in this article

p605-a
on p.605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bloom S. R., Polak J. M. Glucagonomas, VIPomas and somatostatinomas. Clin Endocrinol Metab. 1980 Jul;9(2):285–297. doi: 10.1016/s0300-595x(80)80034-x. [DOI] [PubMed] [Google Scholar]
Finlayson N. Cholecystectomy for gall stones. BMJ. 1989 Jan 21;298(6667):133–134. doi: 10.1136/bmj.298.6667.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
Lamberts S. W. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr Rev. 1988 Nov;9(4):417–436. doi: 10.1210/edrv-9-4-417. [DOI] [PubMed] [Google Scholar]
Lembcke B., Creutzfeldt W., Schleser S., Ebert R., Shaw C., Koop I. Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion. 1987;36(2):108–124. doi: 10.1159/000199408. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES